The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

psm3mkv: A package to evaluate the fit and efficiency of three state oncology cost-effectiveness model structures

R-CMD-check Codecov test coverage CRAN status CRAN Downloads

The goal of psm3mkv is to evaluate the efficiency and fit of certain three state model structures to data typical from an oncology clinical trial, as described in an accompanying article (Muston 2024). The package evaluates the following structures:

The state transition models differ from each other in that the transition from progressive disease to death is a function of time from baseline in the STM-CF and time from progression in the STM-CR (Jackson 2016; Woods et al. 2020).

The package requires a patient-level dataset of time to progression (TTP), progression-free survival (PFS) and overall survival (OS).

Given this, the package enables:

Where two piece modeling is used, modelers should be advised to take care of interpretation and validity in case different cutoff points are selected for different endpoints.

Additionally, for parametric modeling of STM structures, the model for survival in the progressive disease state (post progression survival, PPS) may be a function of an additional arbitrary explanatory variable. This is intended to enable the exploration of TTP (or some transformation) as a predictor for PPS.

Vignettes

The accompanying vignette("example") illustrates how the package can be used for the one-piece parametric and spline modeling.

A second vignette, vignette("background-mortality") illustrates how, after fitting models, estimates of restricted mean durations in health states can be calculated after constraining for background mortality from a given life table. Survival is assumed to be no greater than in a background lifetable.

Installation

The package requires version R >= 4.1.0 due to use of the native pipe. Please ensure R is updated first.

Latest stable release

Install the latest stable release from CRAN:

install.packages("psm3mkv")

Development version

Install the latest development version from GitHub (this may not be as stable):

# install.packages("pak")
pak::pak("Merck/psm3mkv@main")

Note that pak::pak() does not build the vignettes by default when installing a package from GitHub, which is ideal because the vignettes can take a long time to generate. You can conveniently view them on the package documentation website.

Additional dependencies

Running the vignettes requires additional dependencies, which are all either imported by or suggested by psm3mkv. Thus you can ensure they are all installed by specifying dependencies = TRUE.

pak::pak("Merck/psm3mkv@*release", dependencies = TRUE)

Citation

If you use this software, please cite it as below.

Muston, D. 2024. “Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit.” Applied Health Economics and Health Policy. DOI: 10.1007/s40258-024-00884-2

A BibTeX entry for LaTeX users is

@article{muston2024informing,
  author  = {Dominic Muston},
  title   = {Informing structural assumptions for three state oncology cost-effectiveness models through model efficiency and fit},
  journal = {Applied Health Economics and Health Policy},
  year    = {2024},
  doi     = {10.1007/s40258-024-00884-2}
}

References

Jackson, Christopher. 2016. “flexsurv: A Platform for Parametric Survival Modeling in R.” Journal of Statistical Software 70 (8): 1–33.

Woods, Beth S, Eleftherios Sideris, Stephen Palmer, Nick Latimer, and Marta Soares. 2020. “Partitioned Survival and State Transition Models for Healthcare Decision Making in Oncology: Where Are We Now?” Value in Health 23 (12): 1613–1621.

Royston, Patrick, and Mahesh KB Parmar. 2002. “Flexible Parametric Proportional-Hazards and Proportional-Odds Models for Censored Survival Data, with Application to Prognostic Modelling and Estimation of Treatment Effects.” Statistics in Medicine 21 (15): 2175–2197.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.